2025-10-31 19:41:23
Latest Post
Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores
Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore
LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores
Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26
Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores
Stock Report
Fredun Pharmaceuticals Ltd Q2FY22 PAT soars to Rs. 1.83 crore
Posted On : 2021-11-07 16:51:46( TIMEZONE : IST )
Fredun Pharmaceuticals Ltd has reported Standalone financial results for the period ended September 30, 2021.
Financial Results (Q2 FY2022) - QoQ Comparison
The company has reported total income of Rs. 54.7624 crores during the period ended September 30, 2021 as compared to Rs. 45.2494 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs. 1.8397 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 0.3283 crores for the period ended June 30, 2021.
The company has reported EPS of Rs. 4.61 for the period ended September 30, 2021 as compared to Rs. 0.82 for the period ended June 30, 2021.
| Financials | Q2 FY2022 | Q1 FY2022 | % Change |
| Total Income | ₹ 54.7624 crs | ₹45.2494 crs |  21.02% |
| Net Profit | ₹1.8397 crs | ₹0.3283 crs | 460.37% |
| EPS | ₹4.61 | ₹0.82 | 462.20% |
Financial Results (Q2 FY2022) - YoY Comparison
The company has reported total income of Rs. 54.7624 crores during the period ended September 30, 2021 as compared to Rs.33.5997 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.1.8397 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.0.8265 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.4.61 for the period ended September 30, 2021 as compared to Rs.2.07 for the period ended September 30, 2020.
| Financials | Q2 FY2022 | Q2 FY2021 | % Change |
| Total Income | ₹ 54.7624 crs | ₹33.5997 crs | 62.98% |
| Net Profit | ₹1.8397 crs | ₹0.8265 crs | 122.59% |
| EPS | ₹4.61 | ₹2.07 | 122.71% |
Financial Results (Half Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.100.0118 crores during the 6 Months period ended September 30, 2021 as compared to Rs.47.3424 crores during the 6 Months period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.2.1680 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.0.8627 crores for the 6 Months period ended September 30, 2020.
The company has reported EPS of Rs.5.43 for the 6 Months period ended September 30, 2021 as compared to Rs.2.16 for the 6 Months period ended September 30, 2020.
| Financials | Half Year Ended FY2022 | Half Year Ended FY2021 | % Change |
| Total Income | ₹100.0118 crs | ₹47.3424 crs | 111.25% |
| Net Profit | ₹2.1680 crs | ₹0.8627 crs | 151.30% |
| EPS | ₹5.43 | ₹2.16 | 151.39% |
Shares of Fredun Pharmaceuticals Ltd was last trading in BSE at Rs. 506.40 as compared to the previous close of Rs. 506.65. The total number of shares traded during the day was 2070 in over 106 trades.
The stock hit an intraday high of Rs. 519.00 and intraday low of 490.00. The net turnover during the day was Rs. 1050086.00.
